Picture of Cosmos Pharmaceutical logo

3349 — Cosmos Pharmaceutical Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Annual cashflow statement for Cosmos Pharmaceutical, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

2022
May 31st
2023
May 31st
2024
May 31st
2025
May 31st
2026
May 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line33,04832,77333,71942,37244,218
Depreciation
Non-Cash Items-187315636992902
Unusual Items
Other Non-Cash Items
Changes in Working Capital-15,7773,978896-13,126-10,905
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities32,19454,43455,17552,46758,791
Capital Expenditures-43,497-46,636-55,810-53,326-70,462
Purchase of Fixed Assets
Other Investing Cash Flow Items-220-2,477-1,519-2,122-11,441
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-43,717-49,113-57,329-55,448-81,903
Financing Cash Flow Items-2-3-1-2-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6,2223,2458,5277,71719,315
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-17,7458,5666,3734,736-3,797